Travert G - Search Results

1

Guillot M, Travert G, Roussey M, Figarella C, Vidailhet M. Guillot M, et al. Among authors: travert g. Arch Pediatr. 2001 Dec;8 Suppl 5:833s-837s. doi: 10.1016/s0929-693x(01)80004-x. Arch Pediatr. 2001. PMID: 11811052 French. No abstract available.

2

[National neonatal screening program for cystic fibrosis: management and organization].

Grosskopf C, Farriaux JP, Vidailhet M, Briard ML, Navarro J, Turck D, Travert G, Belot V, Bloch J, Roussel P. Grosskopf C, et al. Among authors: travert g. Arch Pediatr. 2003 Sep;10 Suppl 2:364s-369s. doi: 10.1016/s0929-693x(03)90054-6. Arch Pediatr. 2003. PMID: 14671936 French.

3

[Evaluation of diagnosis and follow-up in screened children with cystic fibrosis in Normandy].

Brouard J, Lecoq I, Viel JF, Guillot M, Laurans M, Laroche D, Travert G, Duhamel JF. Brouard J, et al. Among authors: travert g. Arch Pediatr. 2001 Aug;8 Suppl 3:603-609. doi: 10.1016/s0929-693x(01)80015-4. Arch Pediatr. 2001. PMID: 11683083 French.

4

[Infantile hypothyroidism in a 3-and-a-half-year-old child. Value and limitations of neonatal screening tests based on measurement of TSH in dried blood].

Guillot M, Lévêque C, Travert G, Richter B. Guillot M, et al. Among authors: travert g. Arch Fr Pediatr. 1986 Dec;43(10):825-6. Arch Fr Pediatr. 1986. PMID: 3827516 French. No abstract available.

5

[Neonatal screening of cystic fibrosis: which benefits?].

Brouard J, Laurans M, Arion A, Kauffmann D, Sevin I, Laroche D, Travert G, Duhamel JF. Brouard J, et al. Among authors: travert g. Arch Pediatr. 2005 Jun;12(6):643-5. doi: 10.1016/j.arcped.2005.04.017. Arch Pediatr. 2005. PMID: 15904756 Review. French. No abstract available.

6

[High level of immunoreactive circulating trypsin in primary myocardiopathy in cystic fibrosis].

Guesnu M, Feigelson J, Travert G, Vidailhet M, Navarro J. Guesnu M, et al. Among authors: travert g. Arch Fr Pediatr. 1982 Feb;39(2):127-8. Arch Fr Pediatr. 1982. PMID: 7073435 French. No abstract available.

7

[Disclosure of severe neonatal uro-nephropathy by determination of immunoreactive trypsin].

Travert G, Madjidi A, Guillot M, Duhamel JF. Travert G, et al. Arch Fr Pediatr. 1987 Oct;44(8):619. Arch Fr Pediatr. 1987. PMID: 3442465 French. No abstract available.

8

[A new strategy of neonatal screening for cystic fibrosis. The association of immunoreactive trypsin and molecular biology in dried blood].

Laroche D, Peres O, Briard ML, Lemonnier F, Pasquet-Ferre C, Blandin C, Travert G, Fernandez Y. Laroche D, et al. Among authors: travert g. Arch Fr Pediatr. 1990 Apr;47(4):251-3. Arch Fr Pediatr. 1990. PMID: 2363611 French.

9

[Must the perspective of the gene therapy modify the screening strategy of cystic fibrosis?].

Duhamel JF, Travert G, Brouard J. Duhamel JF, et al. Among authors: travert g. Arch Pediatr. 1995 Jan;2(1):8-10. doi: 10.1016/0929-693x(96)89801-0. Arch Pediatr. 1995. PMID: 7735432 Review. French. No abstract available.

10

The application of PCR amplification and the polymorphic marker KM.19 to dried blood spots: comparison with deletion 508 for the confirmation of the neonatal screening test for cystic fibrosis.

Laroche D, Travert G. Laroche D, et al. Among authors: travert g. Pediatr Pulmonol Suppl. 1991;7:19-22. doi: 10.1002/ppul.1950110705. Pediatr Pulmonol Suppl. 1991. PMID: 1782124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters